title: Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy.
abstract: Systemic lupus erythematosus (SLE) is a multi-system inflammatory disorder characterized by the presence of several autoantibodies, including anti-double-stranded DNA. Neuropsychiatric (NP)LE contributes to the prognosis of SLE, and is divided into 19 NPLE syndromes. Its mechanisms are mediated through autoantibodies, complement components, and cytokines. The pathophysiology and diagnosis of NPLE are diverse and complicated. Recent studies have shown that several autoantibodies cross-react with human brain tissue and cause NPLE symptoms in SLE. It is known that in mice, depression and hippocampus-related memory impairment are induced by anti-ribosomal P antibody and anti-NR2 antibody, respectively. In a BMC Medicine research article, Kivity et al. demonstrated novel work showed that the 16/6 Id antibody impaired visual memory and spatial memory by causing hippocampal injury in mice. Given differences in the cross-reactivity of each autoantibody with the nervous system, the clinical features might be different and diverse in NPLE. Identification of autoantibody targets could lead to the development of novel therapies. Investigators and clinicians should consider not only the inhibition of autoantibody synthesis but also the protection of neuronal cells in the treatment strategy for NPLE.See related Research article: http://www.biomedcentral.com/1741-7015/11/90.
authors.affiliation: Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo, 162-0054, Japan. tgono@ior.twmu.ac.jp
authors.forename: Takahisa
authors.initials: T
authors.lastname: Gono
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: Hisashi
authors.initials: H
authors.lastname: Yamanaka
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000633:toxicity*; D060825:Cognitive Dysfunction / Q000139:chemically induced*; D004660:Encephalitis / Q000139:chemically induced*; D005260:Female; D006801:Humans
chemical_list: D000906:Antibodies
references.citation: J Clin Invest. 1985 Jul;76(1):287-94
references.pmid: 3874881
references.citation: Nat Med. 2001 Nov;7(11):1189-93
references.pmid: 11689882
references.citation: Lancet. 1984 Aug 25;2(8400):417-22
references.pmid: 6147499
references.citation: N Engl J Med. 2011 Dec 1;365(22):2110-21
references.pmid: 22129255
references.citation: J Exp Med. 2007 Dec 24;204(13):3221-34
references.pmid: 18056288
references.citation: Arthritis Rheum. 1999 Apr;42(4):599-608
references.pmid: 10211873
references.citation: J Rheumatol. 2004 Nov;31(11):2093-8
references.pmid: 15517616
references.citation: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18569-74
references.pmid: 20921396
references.citation: Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10255-9
references.pmid: 21646518
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19854-9
references.pmid: 17170137
references.citation: Arthritis Rheum. 2007 Mar;56(3):938-48
references.pmid: 17328071
references.citation: Clin Immunol Immunopathol. 1984 May;31(2):261-71
references.pmid: 6370522
references.citation: Arthritis Rheum. 2011 Dec;63(12):3952-9
references.pmid: 22012858
references.citation: BMC Med. 2013 Apr 04;11:90
references.pmid: 23556432